Literature DB >> 20434197

Urinary cytology in era of fluorescence endoscopy: redefining the role of an established method with a new reference standard.

Stefan Tritschler1, Maria-Luisa Sommer, Julia Straub, Yasemin Hocaoglu, Derya Tilki, Frank Strittmatter, Dirk Zaak, Christian Stief, Alexander Karl.   

Abstract

OBJECTIVES: To assess whether the use of fluorescence endoscopy (FE) decreases the clinical value of urinary cytology compared with the use of white light endoscopy (WLE).
METHODS: The endoscopic, cytologic, and histologic findings of patients who had undergone transurethral resection of the bladder with or without FE were reviewed. The number and characteristics of the tumors that had been overlooked by WLE or FE but detected by cytology were analyzed. An assessment of whether the sensitivity and specificity of urinary cytology changed according to the use of FE or WLE was conducted.
RESULTS: The data from 1705 patients were included. Histologic findings were obtained from 238 patients using WLE and from 1467 patients using FE. Histologically confirmed malignancy was found in 641 patients, and the disease of 1064 was classified as benign. FE was superior to WLE in sensitivity in the detection of bladder cancer (94.3% vs 86.3%, P <.05). Cytology detected 53 of 88 tumors that were not detected by WLE (47 high-grade tumors); 31 tumors were overlooked by FE, of which 20 were detected by cytology (12 were high-grade tumors). The sensitivity and specificity of cytology was 66.0% and 78.4%, respectively. The specificity of cytology using WLE and FE was 75% and 79.1% (P >.05) and the sensitivity was 61.4% and 67.4% (P >.05), respectively.
CONCLUSIONS: Although FE demonstrated a great sensitivity, cytology still has a role even when using FE, because a small group of patients with high-grade tumors were detected by urinary cytology only.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20434197     DOI: 10.1016/j.urology.2010.01.083

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  5 in total

Review 1.  [Urine cytology - update 2013. A systematic review of recent literature].

Authors:  M Böhm; F vom Dorp; M Schostak; O W Hakenberg
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

2.  [Urine marker systems for diagnosis of urothelial cancer].

Authors:  S Tritschler; F Strittmatter; A Karl; C Stief
Journal:  Urologe A       Date:  2013-07       Impact factor: 0.639

3.  Methylation markers for urine-based detection of bladder cancer: the next generation of urinary markers for diagnosis and surveillance of bladder cancer.

Authors:  Thomas Reinert
Journal:  Adv Urol       Date:  2012-06-18

4.  Diagnostic significance of microRNAs as novel biomarkers for bladder cancer: a meta-analysis of ten articles.

Authors:  Hong-Bin Shi; Jia-Xing Yu; Jian-Xiu Yu; Zheng Feng; Chao Zhang; Guang-Yong Li; Rui-Ning Zhao; Xiao-Bo Yang
Journal:  World J Surg Oncol       Date:  2017-08-03       Impact factor: 2.754

5.  Improved urine DNA methylation panel for early bladder cancer detection.

Authors:  Qixun Fang; Xu Zhang; Qing Nie; Jianqiang Hu; Shujun Zhou; Chaojun Wang
Journal:  BMC Cancer       Date:  2022-03-03       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.